NCT03085173 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03085173
Title	A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Memorial Sloan Kettering Cancer Center
Indications	chronic lymphocytic leukemia acute lymphoblastic leukemia B-cell lymphoma chronic myeloid leukemia Burkitt lymphoma diffuse large B-cell lymphoma follicular lymphoma marginal zone lymphoma lymphoplasmacytic lymphoma
Therapies	EGFRt/19-28z/4-1BBL CAR T cells
Age Groups:	senior \| adult
Covered Countries	USA

NCT03085173
Clinical Trial Detail